These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 1338200)
1. Immunogenicity of enhanced potency inactivated polio vaccine. Singh J; Ravi RN; Dutta AK; Kumari S; Khare S Indian Pediatr; 1992 Nov; 29(11):1353-6. PubMed ID: 1338200 [TBL] [Abstract][Full Text] [Related]
2. Immunogenicity to poliovirus type 2 following two doses of fractional intradermal inactivated poliovirus vaccine: A novel dose sparing immunization schedule. Anand A; Molodecky NA; Pallansch MA; Sutter RW Vaccine; 2017 May; 35(22):2993-2998. PubMed ID: 28434691 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of inactivated poliovirus vaccine in India. Krishnan R; Jadhav M; John TJ Bull World Health Organ; 1983; 61(4):689-92. PubMed ID: 6605215 [TBL] [Abstract][Full Text] [Related]
4. Serological and virological assessment of oral and inactivated poliovirus vaccines in a rural population in Kenya. Kok PW; Leeuwenburg J; Tukei P; van Wezel AL; Kapsenberg JG; van Steenis G; Galazka A; Robertson SE; Robinson D Bull World Health Organ; 1992; 70(1):93-103. PubMed ID: 1568283 [TBL] [Abstract][Full Text] [Related]
5. Response to immunization against polio after allogeneic marrow transplantation. Ljungman P; Duraj V; Magnius L Bone Marrow Transplant; 1991 Feb; 7(2):89-93. PubMed ID: 1646664 [TBL] [Abstract][Full Text] [Related]
6. Decision analysis in planning for a polio outbreak in the United States. Jenkins PC; Modlin JF Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814 [TBL] [Abstract][Full Text] [Related]
7. Anomalous observations on IPV and OPV vaccination. John TJ Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328 [TBL] [Abstract][Full Text] [Related]
8. Randomized trial of inactivated and live polio vaccine schedules in Guatemalan infants. Asturias EJ; Dueger EL; Omer SB; Melville A; Nates SV; Laassri M; Chumakov K; Halsey NA J Infect Dis; 2007 Sep; 196(5):692-8. PubMed ID: 17674310 [TBL] [Abstract][Full Text] [Related]
9. [The vaccine against poliomyelitis, inactivated, concentrated, injectable: analysis of ten years of use in tropical countries]. Drucker J Bull Soc Pathol Exot; 1991; 84(5 Pt 5):866-72. PubMed ID: 1668069 [TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine. Tejedor JC; Moro M; Ruiz-Contreras J; Castro J; Gómez-Campderá JA; Navarro ML; Merino JM; Martín-Ancel A; Roca J; García-del-Río M; Jurado A; Díez-Delgado FJ; Omeñaca F; García-Sicilia J; Boceta R; García-Corbeira P; Jacquet JM; Collard A; Schuerman L; Pediatr Infect Dis J; 2006 Aug; 25(8):713-20. PubMed ID: 16874171 [TBL] [Abstract][Full Text] [Related]
11. A comparative study of reactogenicity and immunogenicity of an oral and an inactivated polio vaccine. Borcić B; Dobrovsak-Sourek V; Kaić B; Ljubicić M Acta Med Croatica; 1998; 52(3):155-8. PubMed ID: 9818437 [TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of a primary course and booster dose of a combined diphtheria, tetanus, acellular pertussis, hepatitis B and inactivated poliovirus vaccine. Meriste S; Lutsar I; Tamm E; Willems P Scand J Infect Dis; 2006; 38(5):350-6. PubMed ID: 16709537 [TBL] [Abstract][Full Text] [Related]
13. Fractional doses of inactivated poliovirus vaccine in Oman. Mohammed AJ; AlAwaidy S; Bawikar S; Kurup PJ; Elamir E; Shaban MM; Sharif SM; van der Avoort HG; Pallansch MA; Malankar P; Burton A; Sreevatsava M; Sutter RW N Engl J Med; 2010 Jun; 362(25):2351-9. PubMed ID: 20573923 [TBL] [Abstract][Full Text] [Related]
14. [A study on immunization of polio vaccine. I. Observation on an improved immunization schedule]. Su W Zhonghua Liu Xing Bing Xue Za Zhi; 1991 Oct; 12(5):281-3. PubMed ID: 1664295 [TBL] [Abstract][Full Text] [Related]
15. Progress with inactivated poliovirus vaccines derived from the Sabin strains. Doi Y; Abe S; Yamamoto H; Horie H; Ohyama H; Satoh K; Tano Y; Ota Y; Miyazawa M; Wakabayashi K; Hashizume S Dev Biol (Basel); 2001; 105():163-9. PubMed ID: 11763324 [TBL] [Abstract][Full Text] [Related]
16. Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age. Black S; Friedland LR; Ensor K; Weston WM; Howe B; Klein NP Pediatr Infect Dis J; 2008 Apr; 27(4):341-6. PubMed ID: 18316985 [TBL] [Abstract][Full Text] [Related]
17. Priming after a fractional dose of inactivated poliovirus vaccine. Resik S; Tejeda A; Sutter RW; Diaz M; Sarmiento L; Alemañi N; Garcia G; Fonseca M; Hung LH; Kahn AL; Burton A; Landaverde JM; Aylward RB N Engl J Med; 2013 Jan; 368(5):416-24. PubMed ID: 23363495 [TBL] [Abstract][Full Text] [Related]
18. [The immunological basis of the administration of DTP-polio vaccine]. Cohen H Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905 [TBL] [Abstract][Full Text] [Related]
19. [Seroconversion after vaccination against pertussis, Haemophilus influenzae type b and poliomyelitis in preterm infants]. Sikora JP; Chlebna-Sokół D Przegl Lek; 2003; 60(11):699-703. PubMed ID: 15058036 [TBL] [Abstract][Full Text] [Related]
20. [Antipoliomyelitis vaccination of young children with a new inactivated vaccine. Serological results]. Grenier B; Viarme F; Roumiantzeff M; Xueref C; Demont F Arch Fr Pediatr; 1985 Apr; 42(4):321-3. PubMed ID: 4004496 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]